PIH doctor reflects on challenges, setbacks, and silver linings for health systems Posted on April 5, 2021 The COVID-19 pandemic has severely disrupted care and services for people living with tuberculosis—until recently the world’s deadliest infectious disease—draining or diverting resources and potentially costing hundreds of thousands of lives that could have Read more…
EndTB clinical trial shortens treatment period, helps dozens return to normal life Posted March 24, 2021 While pregnant with her second child, Maral Shorayeva began experiencing symptoms that felt like a cold or flu, but when she went to give birth to her daughter, doctors recognized that something was wrong. Read more…
Q&A with Dr. Carole Mitnick, PIH’s co-principal investigator of endTB project Tuberculosis is the most deadly infectious disease, killing more than 1.4 million people globally, most of them in resource-poor countries. Some forms of the disease are resistant to treatment and therefore can’t be cured using standard drugs. These multidrug Read more…
PIH Kazakhstan Country Director Dr. Yerkebulan Algozhin is among staff who have recovered from COVID-19 this year, and said facing a pandemic while continuing tuberculosis care has brought his team closer together – as they now prepare for a second wave of the novel virus. When Dr. Yerkebulan Algozhin heard the Read more…
Despite Kazakhstan’s nationwide lockdown that began in March to contain COVID-19, Partners In Health clinicians have continued to examine and provide treatment—in person and online—for tuberculosis patients enrolled in a groundbreaking clinical trial. Clinicians have had to communicate regularly with police to cross checkpoints and have used their own vehicles Read more…
A newly published study with several Partners In Health co-authors showed strong results for using new drugs and shorter treatment regimens to fight severe tuberculosis (TB), adding to the case for faster rollout of the drugs and creating data that already has influenced World Health Organization treatment guidelines, a lead PIH researcher Read more…